Neptune, NJ — August 2025 — JSAS HealthCare, Inc. (JSASHC) is proud to announce it has been awarded funding through a competitive Request for Proposal (RFP) process by the New Jersey Department of Human Services, Division of Mental Health and Addiction Services (NJDMHAS) to establish a Mobile Medication Unit (MMU) for Opioid Use Disorder (OUD).
When it comes to the opioid crisis, collaboration makes all the difference. Join us at the Mobile Health Leadership Summit on August 13-14, 2025, where three industry leaders—including JSAS Healthcare’s Margaret B. Rizzo—will share how they’re driving real change in treatment and recovery. These voices are reshaping how care is delivered, meeting people where they are with compassion, innovation, and action.
Maiysha Ware, NJATOD President, accepted the notable Nyswander/Dole “Marie” Award which is the highest accolade AATOD can bestow on someone in recognition for having made significant contributions in the field of opioid use disorder treatment.
New Jersey is making significant strides in expanding access and eliminating transportation barriers to medication-assisted treatment for opioid use disorders. This is being achieved through the implementation of the New Jersey Department of Human Services, Division of Mental Health and Addiction Services’ (NJDMHAS) Medication Assisted Treatment Initiative (MATI) and Travel Reimbursement and Invoicing Program (TRIP).
